MENLO PARK, Calif. (AP) _ Intersect ENT Inc. (XENT) on Wednesday reported a loss of $4.2 million in its second quarter.

The Menlo Park, California-based company said it had a loss of 14 cents per share.

The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

The maker of absorbable nasal implants posted revenue of $26.3 million in the period, which missed Street forecasts. Six analysts surveyed by Zacks expected $28.1 million.

For the current quarter ending in October, Intersect ENT said it expects revenue in the range of $23.8 million to $24.3 million.

The company expects full-year revenue in the range of $106 million to $109 million.

Intersect ENT shares have dropped slightly since the beginning of the year. The stock has risen 18 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENT at https://www.zacks.com/ap/XENT